Get the Stockscreener App
149.10
0.78%
-1.12
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $149.10, with a volume of 881.48K.
It is down -0.78% in the last 24 hours and down -3.53% over the past month.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$150.22
Open:
$150.84
24h Volume:
881.48K
Relative Volume:
0.34
Market Cap:
$42.42B
Revenue:
$21.92B
Net Income/Loss:
$1.76B
P/E Ratio:
24.35
EPS:
6.1223
Net Cash Flow:
$2.63B
1W Performance:
-4.88%
1M Performance:
-3.53%
6M Performance:
-19.09%
1Y Performance:
-27.16%
1-Day Range:
$148.40
$151.85
1-Week Range:
$148.40
$157.66
52-Week Range:
$148.40
$213.08
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
149.13 | 42.73B | 21.92B | 1.76B | 2.63B | 6.1223 |
ISRG
Intuitive Surgical Inc
|
464.04 | 166.81B | 10.58B | 3.00B | 2.83B | 8.2437 |
MDLN
Medline Inc
|
44.78 | 38.25B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
75.04 | 37.05B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
217.77 | 32.34B | 5.40B | 1.49B | 1.78B | 10.12 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-26 | Resumed | Goldman | Neutral |
| Feb-10-26 | Resumed | Barclays | Overweight |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Becton Dickinson EVP Michael Feld sells $11,243 in stock - Investing.com
Becton Dickinson (NYSE: BDX) CRO sells 74 common shares in market trade - Stock Titan
Becton Dickinson & Co. stock underperforms Monday when compared to competitors - MarketWatch
Transforming Becton, Dickinson and Company’s global integration landscape - Capgemini
Piper Sandler Trims Becton Dickinson (BDX) PT on Model Revisions - Yahoo Finance
Becton Dickinson & Co. stock underperforms Friday when compared to competitors - MarketWatch
Becton Dickinson and Company (BDX): Gold Standard Defensive Stock - Yahoo Finance
XS276302639 Bond Price and Chart — DUS:XS276302639 - TradingView
Kanawha Capital Management LLC Sells 13,557 Shares of Becton, Dickinson and Company $BDX - MarketBeat
KLP Kapitalforvaltning AS Acquires 65,500 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Stake Reduced by Boston Trust Walden Corp - MarketBeat
TABR Capital Management LLC Makes New $3.81 Million Investment in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Ticino Wealth Takes $1.48 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Khaitan, Clifford Chance act on Becton Dickinson’s global spin-off of its biosciences and diagnostic solut.. - ETLegalWorld.com
Becton Dickinson and Co stock (US0758871091): Is its medtech diversification strong enough for stead - AD HOC NEWS
Deals tracker: Community Health Systems adds surgery centers - Modern Healthcare
What You Need to Know Ahead of Becton, Dickinson and Company's Earnings Release - Yahoo Finance
Becton, Dickinson and Company (BDX) Stock Analysis: A Look at Its 20.77% Potential Upside - DirectorsTalk Interviews
Busey Bank Decreases Position in Becton, Dickinson and Company $BDX - MarketBeat
Lobbying Update: $60,000 of BECTON DICKINSON AND COMPANY lobbying was just disclosed - Quiver Quantitative
Becton Dickinson Stock Offers Stability and Dividends for Investors - HarianBasis.co
RBC Capital Lowers Becton Dickinson Price Target to $175 - HarianBasis.co
KANAWHA CAPITAL MANAGEMENT LLC's Becton Dickinson & Co(BDX) Holding History - GuruFocus
Becton Dickinson & Co stock (US0758871091): Why Google Discover visibility now matters more for medt - AD HOC NEWS
Slocum Gordon & Co LLP Makes New $1.94 Million Investment in Becton, Dickinson and Company $BDX - MarketBeat
KBC Group NV Has $14.85 Million Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson Wins Supply Chain Honors As Valuation Appears Undemanding - Yahoo Finance
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
The Healthcare Stock Built for Investors Who Prioritize Capital Preservation - The Motley Fool
Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $159 - 富途牛牛
Only one medical supplier won all 3 new HIRC awards: BD - Stock Titan
Assetmark Inc. Boosts Holdings in Becton, Dickinson and Company $BDX - MarketBeat
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $175 - 富途牛牛
Third View Private Wealth LLC Takes $4.99 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Stock Holdings Lessened by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Becton, Dickinson and Company’s Bilal Muhsin on the future of Connected Care - Gulf Business
Becton Dickinson And Co: A $5.3 Billion Quarter Signals Limited Growth Momentum - Smartkarma
Massachusetts Financial Services Co. MA Has $1.84 Billion Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Goldman Sachs Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $167 - 富途牛牛
Cardinal Capital Management Inc. Has $23.89 Million Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company (BD) 8-K Filing April 2026 – Company Details, Registered Securities, and Contact Information - Minichart
Becton, Dickinson and Company (BDX) Announces Executive Retireme - GuruFocus
Rick Byrd to Retire from BD - Finviz
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Richard E. Byrd to Retire as President of Interventional at Becton Dickinson - TradingView
After 25 years at BD, a top medical device executive will retire - Stock Titan
Becton, Dickinson and Company (BDX) Stock Price, News, Quote & History - Yahoo! Finance Canada
For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD PureWick Urine Collection System - Finviz
OFI Invest Asset Management Grows Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):